Israeli-Dutch Innovation Center

#85 Dutch led coronavirus funded proposals for the Health~Holland call is open to international partners

  • Industry Life sciences and health
  • Online since 2020-04-03

Dutch led coronavirus funded proposals for the Health~Holland call is open to international partners.

Topsector Life Sciences & Health (;Health~Holland) intends to invest in the field of COVID-19. If you have a high end public-private research proposal in the field of COVID-19, we are inviting you to send us an e-mail including: 

  1. a short description of the project
  2. a list of (potential) consortium partners
  3. a rough estimate of the budget
  4. the expected start- and end date

Please note that any definite projects must comply with the match call regulations.

After receiving your e-mail, we will aim to contact you by cellphone within 1 working day to discuss the possibilities. Please include your cellphone details in your email.

Finally, the email can be sent to: [email protected], until the 10th of April 2020.

Go to website

Maybe you like this as well

  • Chemistry: Dutch Israeli cooperation with Brightlands Chemelot Campus in the Netherlands

    Brightlands Chemelot Campus in the Netherlands is looking for R&D cooperation with Israeli companies and research institutions and also offers a physi...

    Read more
  • Energy: The Netherlands: Executive Programme New Energy Realities - a few places left!

    Read more
  • Health: Israeli Med-tech startup in the field of Obesity and Overweight is looking for Dutch investors

    Melcap system is a dynamic Israeli startup in the medical device and health sector which developed a novel, cost-effective, wireless, ingestible capsu...

    Read more

Get in touch

Do you need some help with extending your network in both The Netherlands or Israel. Connect with us and talk about the possibilities.

  • Israeli-Dutch Innovation Center
    Embassy of the Kingdom of the Netherlands in Israel

  • 14 Abba Hillel Street, Ramat Gan 5250607

  • +972 (0) 52 9530 385

  • [email protected]